Results 191 to 200 of about 646,520 (340)

Pancreatic Disease and Acute Intermittent Porphyria

, 1977
Camille Buffet, J C Chaput, D. Labayle F. Gayral, J P Etienne   +3 more
openalex   +1 more source

Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives

Advanced Materials, EarlyView.
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin, Liliang Ouyang, Khoon S. Lim, Antonella Motta, Devid Maniglio, Lorenzo Moroni, Carlos Mota   +6 more
wiley   +1 more source

RalGAP complexes control secretion and primary cilia in pancreatic disease. [PDF]

Life Sci Alliance
Apken LH, Barz H, Beel S, Michalke E, Rasche R, Verma A, Ricker A, Nüsse H, Klingauf J, Kerl K, Wardelmann E, Kümmel D, Steinestel K, Pethő Z, Meisterernst M, Oeckinghaus A.   +15 more
europepmc   +1 more source

Pancreatic duct abnormalities in gall stone disease: an endoscopic retrograde cholangiopancreatographic study. [PDF]

, 1990
S P Misra, Parul Gulati, Vijayanand Choudhary, B S Anand   +3 more
openalex   +1 more source

MUTE‐Seq: An Ultrasensitive Method for Detecting Low‐Frequency Mutations in cfDNA With Engineered Advanced‐Fidelity FnCas9

Advanced Materials, EarlyView.
An advanced‐fidelity CRISPR nuclease, FnCas9‐AF2, is rationally engineered to discriminate single‐base mismatches with unprecedented level precision. Integrated into the MUTE‐Seq workflow, FnCas9‐AF2 depletes wild‐type cell‐free DNA, thereby exposing rare tumor‐derived mutant DNA (a molecular “needle in a haystack”).
Sunghyeok Ye, Jin‐Soo Kim, Myungshin Kim, Ki‐Yeon Kim, Yoon‐Ho Won, Taegun Park, Sungjae An, Haerin Jeong, Hee‐Joon Chung, In Seon Lee, Myoung‐Hee Kang, Chan Young Kang, Mi Young Kim, Jae Ho Chung, Jeong‐An Gim, Woochang Hwang, Yonggoo Kim, Song Cheol Kim, Sungho Lee, Junho K Hur, Junseok W Hur   +20 more
wiley   +1 more source

Unveiling CTRB2, RSPO3, KLOTB, and ROR1 as obesity-pancreatic disease association proteins: a comprehensive Mendelian randomization study. [PDF]

Gastroenterol Rep (Oxf)
Zhou C, Ruan X, Che T, Zhang Y, Yuan S, Li X, Zheng J, Cao X, Chen J, Wang X, Zou D.   +10 more
europepmc   +1 more source

Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension. [PDF]

Gastroenterol Res Pract, 2020
Zheng K, Guo X, Feng J, Bai Z, Shao X, Yi F, Zhang Y, Zhang R, Liu H, Romeiro FG, Qi X.   +10 more
europepmc   +1 more source

Diagnosis of Pancreatic Diseases by Scintigraphy

, 1974
Masatada TANABE, Toyosato TAMAI, Yoshio Hiraki, Kazuhiko Ehara, Hisao Takagi, Yoshio Haisa, Yasumasa KUMADA, Hiroshi Wakabayashi, Gonosuke Hashimoto   +8 more
openalex   +2 more sources

Probiotic‐Based Materials as Living Therapeutics

Advanced Materials, EarlyView.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio, Graham J. Day, Manuel Salmeron‐Sanchez   +2 more
wiley   +1 more source

Based on the immune system: the role of the IL-2 family in pancreatic disease. [PDF]

Front Immunol
Zhu Y, Lu Z, Wang Z, Liu J, Ning K.
europepmc   +1 more source